OZ Minerals is set to gain full control of the West Musgrave nickel-copper asset in Western Australia after announcing a friendly takeover of project partner Cassini Resources.…
The median mobile download speed from global internet tracker Ookla shows a higher median download speed on mobile and fixed internet than before the lockdown. The data is for the week ended June 14 (chart 4). People use the internet more when they are at home, for work, and for entertainment, leading to a fall in download speeds because of increased load. More people are heading back to work now.
Two indicators which haven’t seen as much of a recovery are traffic congestion and pollution levels. Mumbai and New Delhi both saw their traffic congestion levels begin to taper off after rising in recent times. The numbers are based on location tracker TomTom International (chart 5).
Business Standard also looks at nitrogen dioxide levels that are emitted because of industrial activity and from vehicles. The levels remain muted in Delhi and Mumbai (chart 6, 7). Delhi had shown some recovery but the gap over 2019 show signs of widening again.
Gilead Sciences Inc expects supply of its potential Covid-19 drug remdesivir to exceed two million courses by year-end, the company said on Monday, more than double its previous target of 1 million.
The company also said it planned to start trials of an easier-to-use inhaled version of the antiviral drug, currently administered only intravenously, by August.
Remdesivir is at the forefront in the fight against the virus after the drug helped shorten hospital recovery times in a clinical trial.
But producing and supplying billions of doses remain major concerns as the fast-spreading respiratory illness overwhelms healthcare systems around the world.
“We will continue to collaborate globally to ensure sufficient worldwide supply,” Gilead Chief Executive Officer Daniel O’Day said in a statement. (https://bit.ly/3eqpEJ9)
Two major Indian drugmakers – Hetero Labs and Cipla Ltd – on Sunday gained approval to begin selling their generic versions of remdesivir in the country. Another Indian drugmaker Glenmark expects the treatment to be priced at 5,000 to 6,000 rupees ($66-$79) for a 100 milligram dose.
Remdesivir has not been priced yet in the United States.
Gilead’s expectations of two
Nigeria on Monday said West African regional body ECOWAS had backed its choice to head the World Trade Organization (WTO) as the continent looks to get behind one candidate.
The WTO this month kicked off the process for selecting a new director-general, after its current chief Roberto Azevedo decided to leave a year early.
Diplomats acknowledge that Africa may be in line for the post since the continent has never before provided a WTO director-general.
Nigeria is lobbying for its former finance minister Ngozi Okonjo-Iweala to get the top job.
She currently serves as board chair of GAVI, the Vaccine Alliance, and as a special African Union (AU) envoy to help fight the coronavirus pandemic.
Nigeria’s foreign ministry said in a statement that ECOWAS heads of state had thrown their support behind her candidacy due to “her long years of managerial experience at the top echelons of multilateral institutions”.
The AU has voiced the ambition to settle on a single African candidate to put forward, but it remains unclear if it will manage to do so before the July 8 deadline.
Several other candidates from the continent appear likely to be in the running, including former Egyptian diplomat Hamid Mamdou,